| Ticker Details |
|
Nuvation Bio Inc.
|
| IPO Date: |
August 24, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$2.43B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.16 | 3.61%
|
| Avg Daily Range (30 D): |
$0.21 | 3.31%
|
| Avg Daily Range (90 D): |
$0.19 | 3.49%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.1M |
| Avg Daily Volume (30 D): |
5.53M |
| Avg Daily Volume (90 D): |
5.35M |
| Trade Size |
| Avg Trade Size (Sh.): |
205 |
| Avg Trade Size (Sh.) (30 D): |
164 |
| Avg Trade Size (Sh.) (90 D): |
185 |
| Institutional Trades |
| Total Institutional Trades: |
1,058 |
| Avg Institutional Trade: |
$2.16M |
| Avg Institutional Trade (30 D): |
$2.21M |
| Avg Institutional Trade (90 D): |
$1.93M |
| Avg Institutional Trade Volume: |
.44M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.76M |
| Avg Closing Trade (30 D): |
$3.03M |
| Avg Closing Trade (90 D): |
$2.84M |
| Avg Closing Volume: |
523.95K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-.44
|
$-.18
|
$.02
|
|
Diluted EPS
|
$-.44
|
$-.18
|
$.01
|
|
Revenue
|
$169.9M
|
$31.69M
|
$83.23M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-149.83M
|
$-62.84M
|
$5.4M
|
|
Operating Income / Loss
|
$-137.63M
|
$-51.04M
|
$3.88M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$10.63M
|
$133.21M
|
$-38.7M
|
|
PE Ratio
|
|
|
|
|
|
|